After establishing the Patient-derived xenograft (PDX) models of CRC as described in the ‘Materials and Methods’ section, six PDX models with different MARVELD1 levels were selected to carry out experiments (Fig. 7d). The gene discussed is MARVELD1; the disease is colorectal carcinoma.